Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impetigo treatment comparison in New Zealand school children
ACTRN12616000356460Phase 4Completed
- Sponsor
- Dr Alison Leversha
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fusidic acid and hydrogen peroxide in impetigo, sponsored by Dr Alison Leversha. Started Sep 2017; status: completed.
02
Drugs
fusidic acidhydrogen peroxide
03
Conditions
impetigo
Beyond the preview
Go deeper on ACTRN12616000356460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000356460.